tiprankstipranks
Trending News
More News >
Immunocore Holdings (IMCR)
NASDAQ:IMCR
US Market

Immunocore Holdings (IMCR) Financial Statements

Compare
244 Followers

Immunocore Holdings Financial Overview

Immunocore Holdings's market cap is currently $1.64B. The company's EPS TTM is $0; its P/E ratio is -45.67; Immunocore Holdings is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 297.57M£ 247.77M£ 249.43M£ 144.23M£ 36.48M
Gross Profit£ 291.36M£ 239.38M£ 248.39M£ 138.94M£ 36.48M
Operating Income£ -33.74M£ -56.28M£ -59.65M£ -42.77M£ -174.59M
EBITDA£ 387.18K£ -38.50M£ -51.65M£ -38.35M£ -166.72M
Net Income£ -26.42M£ -40.81M£ -55.29M£ -43.46M£ -180.03M
Balance Sheet
Cash & Short-Term Investments£ 864.15M£ 820.38M£ 442.63M£ 402.47M£ 321.06M
Total Assets£ 1.07B£ 1.01B£ 597.00M£ 526.76M£ 407.28M
Total Debt£ 43.56M£ 432.72M£ 84.03M£ 81.45M£ 86.16M
Net Debt£ -424.15M£ -23.01M£ -358.59M£ -321.02M£ -234.90M
Total Liabilities£ 686.24M£ 648.79M£ 228.16M£ 187.86M£ 175.76M
Stockholders' Equity£ 381.03M£ 360.72M£ 368.84M£ 338.90M£ 231.53M
Cash Flow
Free Cash Flow£ -11.20M£ 20.89M£ -2.48M£ -51.41M£ -144.49M
Operating Cash Flow£ -7.97M£ 26.06M£ 2.94M£ -49.21M£ -143.11M
Investing Cash Flow£ -12.16M£ -355.13M£ -5.42M£ -2.20M£ -1.28M
Financing Cash Flow£ 9.20M£ 343.88M£ 34.35M£ 145.44M£ 288.19M
Currency in GBP

Immunocore Holdings Earnings and Revenue History

Immunocore Holdings Debt to Assets

Immunocore Holdings Cash Flow

Immunocore Holdings Forecast EPS vs Actual EPS